Expert highlights importance of Hemovigilance Project

04/14/2010 | HealthLeaders Media

It is crucial for the U.S. to develop a data system on blood transfusion-related adverse events that would be readily available and accessible, making it easier to track these events, said Dr. Paul Ness, editor of the journal Transfusion. The hemovigilance system would provide hospitals with the opportunity to measure whether the changes they make have an effect on patient outcomes.

View Full Article in:

HealthLeaders Media

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX